FI105913B - Menetelmä farmaseuttisesti arvokkaiden bentsomorfaanien valmistamiseksi - Google Patents

Menetelmä farmaseuttisesti arvokkaiden bentsomorfaanien valmistamiseksi Download PDF

Info

Publication number
FI105913B
FI105913B FI923050A FI923050A FI105913B FI 105913 B FI105913 B FI 105913B FI 923050 A FI923050 A FI 923050A FI 923050 A FI923050 A FI 923050A FI 105913 B FI105913 B FI 105913B
Authority
FI
Finland
Prior art keywords
alkyl
trimethyl
hydroxy
benzomorphane
methoxypropyl
Prior art date
Application number
FI923050A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI923050A0 (fi
FI923050L (fi
Inventor
Helmut Ensinger
Matthias Grauert
Herbert Merz
Ilse Streller
Werner Stransky
Adrian Carter
Enzio Mueller
Franz Josefy Kuhn
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI923050A0 publication Critical patent/FI923050A0/fi
Publication of FI923050L publication Critical patent/FI923050L/fi
Application granted granted Critical
Publication of FI105913B publication Critical patent/FI105913B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
FI923050A 1991-07-02 1992-07-01 Menetelmä farmaseuttisesti arvokkaiden bentsomorfaanien valmistamiseksi FI105913B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4121821 1991-07-02
DE4121821A DE4121821A1 (de) 1991-07-02 1991-07-02 Neue benzomorphane und ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
FI923050A0 FI923050A0 (fi) 1992-07-01
FI923050L FI923050L (fi) 1993-01-03
FI105913B true FI105913B (fi) 2000-10-31

Family

ID=6435223

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923050A FI105913B (fi) 1991-07-02 1992-07-01 Menetelmä farmaseuttisesti arvokkaiden bentsomorfaanien valmistamiseksi

Country Status (24)

Country Link
EP (1) EP0521422B1 (cs)
JP (1) JP3324785B2 (cs)
KR (1) KR100251256B1 (cs)
AT (1) ATE137749T1 (cs)
AU (1) AU657330B2 (cs)
CA (1) CA2072814C (cs)
CZ (1) CZ286949B6 (cs)
DE (2) DE4121821A1 (cs)
DK (1) DK0521422T3 (cs)
ES (1) ES2086585T3 (cs)
FI (1) FI105913B (cs)
GR (1) GR3020124T3 (cs)
HK (1) HK1003111A1 (cs)
HU (1) HU220873B1 (cs)
IE (1) IE74400B1 (cs)
IL (1) IL102361A (cs)
MX (1) MX9203845A (cs)
NO (1) NO178263C (cs)
NZ (1) NZ243388A (cs)
PH (1) PH31430A (cs)
SG (1) SG43001A1 (cs)
SK (1) SK280776B6 (cs)
TW (1) TW214547B (cs)
ZA (1) ZA924883B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan
DE19740110A1 (de) * 1997-09-12 1999-03-18 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JPH1196519A (ja) * 1997-09-17 1999-04-09 Alps Electric Co Ltd スピンバルブ型薄膜素子およびその製造方法
US6136980A (en) * 1998-05-01 2000-10-24 Boehringer Ingelheim Kg Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
CN1653050B (zh) 2002-05-17 2013-04-24 詹肯生物科学公司 阿片和阿片样化合物及其用途
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8859580B2 (en) * 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US9862726B2 (en) 2013-12-26 2018-01-09 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
NL7907800A (nl) * 1979-10-23 1981-04-27 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan, farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen en de farmaceutische preparaten.

Also Published As

Publication number Publication date
PH31430A (en) 1998-11-03
AU1868692A (en) 1993-01-07
FI923050A0 (fi) 1992-07-01
AU657330B2 (en) 1995-03-09
SK207592A3 (en) 1997-01-08
NO178263C (no) 1996-02-21
KR930002321A (ko) 1993-02-22
CA2072814C (en) 2003-09-23
SG43001A1 (en) 1997-10-17
ATE137749T1 (de) 1996-05-15
SK280776B6 (sk) 2000-07-11
CA2072814A1 (en) 1993-01-03
ZA924883B (en) 1993-02-24
ES2086585T3 (es) 1996-07-01
CZ207592A3 (en) 1993-08-11
HUT66410A (en) 1994-11-28
MX9203845A (es) 1993-01-01
CZ286949B6 (cs) 2000-08-16
KR100251256B1 (ko) 2000-05-01
JP3324785B2 (ja) 2002-09-17
EP0521422A1 (de) 1993-01-07
GR3020124T3 (en) 1996-08-31
IL102361A0 (en) 1993-01-14
DE59206212D1 (de) 1996-06-13
HK1003111A1 (en) 1998-10-09
EP0521422B1 (de) 1996-05-08
HU220873B1 (en) 2002-06-29
HU9202199D0 (en) 1992-10-28
IL102361A (en) 1997-02-18
NO178263B (no) 1995-11-13
DE4121821A1 (de) 1993-01-14
NZ243388A (en) 1994-11-25
DK0521422T3 (da) 1996-06-10
TW214547B (cs) 1993-10-11
IE922144A1 (en) 1993-01-13
IE74400B1 (en) 1997-07-30
NO922603D0 (no) 1992-07-01
NO922603L (no) 1993-01-04
JPH05201987A (ja) 1993-08-10
FI923050L (fi) 1993-01-03

Similar Documents

Publication Publication Date Title
US5607941A (en) Useful for treating neurodegenerative diseases
FI105913B (fi) Menetelmä farmaseuttisesti arvokkaiden bentsomorfaanien valmistamiseksi
AU658188B2 (en) Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
FI67686C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat
US4320148A (en) 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
UA116542C2 (uk) Сполуки сечовини та їх застосування як інгібіторів ферментів
HK1003111B (en) Benzomorphanes and their use as pharmaceuticals
Szmuszkovicz et al. A new nontricyclic antidepressant agent. Synthesis and activity of N-[trans-2-dimethylaminocyclopentyl]-N-(3, 4-dichlorophenyl) propanamide and related compounds
US5807897A (en) Aminotetralin derivative and compositions and method of use thereof
CN101602754A (zh) 一种二氢黄酮类衍生物及其制备方法和用途
AU643099B2 (en) Pharmaceutically active phenylalkylamino-alkyl compounds
KOJIMA et al. Syntheses of (±)-2-[(inden-7-yloxy) methyl] morpholine hydrochloride (YM-08054, indeloxazine hydrochloride) and its derivatives with potential cerebral-activating and antidepressive properties
RU2060249C1 (ru) Полициклические биоцидные соединения и фармацевтическая композиция на их основе
JPH04500690A (ja) 薬剤組成物
JPS5950671B2 (ja) フェニルエタノ−ルアミン誘導体およびその製造法
CN109422798A (zh) 一种苯基丙酰胺类衍生物的游离碱晶型及其制备方法
US5359070A (en) Unsymmetrical bis-imides as anticancer agents
US4868315A (en) Novel aryloxycycloalkanolaminoalkylene aryl ketones
CA1164464A (en) Derivatives of indole active on the cardiovascular system
KR800000541B1 (ko) 아미노-페닐-에탄올아민의 제조방법
US3414615A (en) 4-trifluoromethylbicyclo[2.2.2]-octane-1-amines and oct-2-ene-1-amines
PL96279B1 (pl) Sposob wytwarzania nowych aminofenyloetanoloamin
King et al. 297. The synthesis of benziminazoles from ortho-phenylenediamines and imino-ethers

Legal Events

Date Code Title Description
MA Patent expired